[ad_1]
Dublin, Nov. 30, 2020 (GLOBE NEWSWIRE) — The “COVID-19: Economic Impact and Market Forecasts for Gross Domestic Product, Tourism/travel, and Medical by Country using 3 scenarios – 2020-2025” report has been added to ResearchAndMarkets.com’s providing.
COVID-19 is popping right into a pandemic. Put together your group for the adjustments starting to happen. Develop an understanding of the dangers and chances and find out how your business and your nation will likely be affected.
This report makes use of an econometric mannequin to forecast the impact that the COVID-19 pandemic could have on the economies of various nations on the earth over the subsequent 5 years. It additionally forecasts the impact on Tourism and affected Medical Markets throughout this timeframe.
The modelling is predicated on Three situations of an infection prevalence forecast individually for every main nation on the earth utilizing financial forecasting mixed with the World Well being Group International Well being Safety Index System and nation particular issue
This in-depth report places you accountable for the numbers you’ll want to put together. Some nations and a few industries will likely be extra affected than others, whereas some is probably not affected in any respect. This analysis makes you an professional in your group. Get the analysis workforce working for you by ordering this complete report.
Report Options:
- The report encompasses a State of affairs Evaluation which summarizes this critical state of affairs and suggests what’s prone to occur. That is supposed for CEOs and Strategic Planners.
- The report has a Information for Executives which is meant for operational executives like Common Managers, Vice Presidents, and Administrators. It has tips for coverage and many others.
- The report has a Information for Funding Managers and Administration Consultants which seems on the image from a finance viewpoint suggesting how industries and shares is perhaps affected.
Key Subjects Coated:
i. COVID-19. Strategic State of affairs Evaluation
ii. COVID-19. Steering for Executives
iii. COVID-19. Steering for Administration Consultants and Funding Advisors
1. Introduction and Market Definition
1.1 What are Pandemics?
1.2 The Position of Zoonosis
1.Three Market Definition
1.3.1 Income Market Measurement
1.3.2 Gross Home Product
1.3.Three Tourism-Motels
1.3.Four Tourism-Floor
1.3.5 Tourism-Air
1.3.6 Tourism-Cruise
1.3.7 Tourism-Different
1.3.Eight Medical -Therapeutic
1.3.9 Medical -Diagnostic
1.3.10 Medical -PPE
1.Four Methodology
1.4.1 Authors
1.4.2 Sources
1.5 Historic Perspective on Pandemics
1.5.1 Hiv/Aids Pandemic 2005-2012
1.5.2 Flu Pandemic 1968
1.5.Three Asian Flu 1956-1958
1.5.Four Spanish Flu 1918
1.5.5 Sixth Cholera Pandemic 1910-1911
1.5.6 Flu Pandemic 1889-1890
1.5.7 The Black Dying 1346-1353
2. The Pandemic Overview
2.1 What’s a Virus?
2.1.1 Is a Virus Alive?
2.1.2 Viral Construction
2.1.Three The Viral Genome
2.1.Four Viral Mutation
2.2 The Coronavirus
2.2.1 Extreme acute respiratory syndrome (SARS)
2.2.2 Center East respiratory syndrome (MERS)
2.2.Three Coronavirus illness 2019 (COVID-19)
2.2.3.1 Indicators and signs
2.2.3.2 Trigger
2.2.3.Three Analysis
2.2.3.Four Prevention
2.2.3.5 Administration
2.2.3.6 Prognosis
2.2.3.7 Epidemiology
2.2.3.10 Misinformation in regards to the outbreak
2.Three Pandemic Diagnostics
2.3.1 Danger Administration-Spark and Unfold
2.3.2 Dx Know-how-Genomic and WGS Position
2.3.Three Dx Know-how- Immunoassay
2.3.Four Dx Know-how-Different
2.3.5 Time to Market and Preparedness Points
2.Four Therapeutics
2.4.1 Vaccine
2.4.2 Twin Position of Vaccines
2.4.2 Antiviral
3. COVID-19 Situations
3.1 Situations Overview
3.2 State of affairs 1. Restricted Unfold & Early Vaccine
3.Three State of affairs 2. Contained Unfold & Midterm Vaccine
3.Four State of affairs 3. Uncontained Unfold & Late Vaccine
4. Current Developments
4.1 Current Developments- Significance and Use This Part
4.1.1 Significance of These Developments
4.1.2 Use This Part
- Generex Indicators Contract to Develop a COVID-19 Vaccine
- Utilized DNA, Takis Biotech Companion To Design COVID-19 Vaccines
- Codagenix Growing a Coronavirus Vaccine
- Breakthrough From MIGAL Analysis Institute in Improvement of COVID-19 Vaccine
- Novavax Advances Improvement of Novel COVID-19 Vaccine
- COVID-19 Causes Air Journey to Fall for first time in 11 Years
- Steep Drop In Chinese language Air Journey Demand
- New Tech May Make Coronavirus Vaccine in File Time
- Vaxart Pronounces Initiation of Coronavirus Vaccine Program
- Coronavirus Detection Take a look at Improvement by Co-Diagnostics
- GeoVax, BravoVax to develop vaccine for coronavirus
- Diagnosing coronavirus within the lab
- Veredus Lab develops take a look at for coronavirus detection
- U.S. Pork Producers worry Pandemic
- First New HIV Pressure in19 Years Recognized
- Flu-Like Epidemic May Kill 80 Mn Globally
- Nipah Virus a International Risk
- New DRC Ebola circumstances confirmed as FDA OKs fast take a look at
- Ontera Awarded Contract for Zika Genotyping Take a look at
- Two NewMembers Be part of International Diagnostics Community
- BARDA Funding Well being Safety Options
5. Profiles of Key Gamers
5.1 Key Gamers-Therapeutics
- Utilized DNA Sciences, Inc
- Codagenix
- GeoVax Labs, Inc
- Takis Biotech
- Evvivax
- Zydus Cadila
- MIGAL Galilee Analysis Institute
- Generex Biotechnology Company
- Moderna Therapeutics
- Novavax
- Bravovax
- Ascletis Pharma
- Janssen Prescription drugs
- Altimmune
- Greffex Inc
- CanSino Biologics, Inc
- ExpreS2ion Biotechnologies ApS
- Clover Biopharmaceuticals
- Vaxil Bio Ltd
- iBio Pharma Inc
- Tonix Prescription drugs
- Curevac
- ImmunoPrecise
- X4 Prescription drugs
- Inovio Prescription drugs
- Innovation Prescription drugs
- CytoDyn
- BIOXYTRAN
- BioCryst Prescription drugs
- Vir Biotechnology
- NanoViricides
- TAKISAWA Know-how Co., Ltd
- Westway Well being
- NabrivaTherapeutics
- NemesisBioscience
- Armata Prescription drugs, Inc
- Lumavita
- Priaxon
- Union Therapeutics
- Enanta Prescription drugs, Inc
- Demuris
- Prommune
- Vaxart
- Alexion Prescription drugs
- SelectXPharmaceuticals, Inc
- TaiGen Biotechnology Co., Ltd
- Abbvie
- KYORIN Pharmaceutical Co., Ltd
- Forge Therapeutics
- Alopexx Vaccine LLC
- Built-in Biotherapeutics
- Hennepin Life Sciences
- Contrafect Company
- Basilea Pharmaceutica Ltd
- AiCuris
- Redx Pharma Plc/ Redx Anti Infectives Ltd
- Centauri Therapeutics Ltd
- Combioxin SA
- Mutabilis SAS
- Vaxdyn
- Vibiosphen
- Bioaster
- Vivexia
- KBP Biosciences
- Merck
- Symphogen
- Johnson & Johnson (Janssen)
- Pfizer
- Allergan
- GlaxoSmithKline
- Novartis
- Gilead Sciences
- AstraZeneca
- Sanofi
- Shionogi Inc
- Cipla
- DSM Sinochem Prescription drugs
- Wockhardt Ltd
- VenatoRx Prescription drugs
5.2 Key Gamers-Diagnostics
- Abbott Diagnostics
- Speed up Diagnostics
- Ador Diagnostics
- Akkoni Biosystems
- Alveo Applied sciences
- Utilized BioCode
- Aus Diagnostics
- BD Diagnostics
- Biocartis
- BioFire Diagnostics
- bioMerieux
- Bio-Rad Laboratories
- Bosch Healthcare Options GmbH
- Cepheid
- Co-Diagnostics
- Cue Well being
- Curetis
- Diagenode Diagnostics
- Diascopic
- Diasorin
- Expedeon
- Fusion Genomics
- GenePOC Diagnostics
- GenMark Dx
- Hologic
- Immunexpress
- Inflammatix
- Invetech
- Janssen Diagnostics
- Karius
- Lexigene
- Luminex
- Mbio Diagnostics
- Meridian Bioscience
- Mesa Biotech
- Mobidiag
- Nanomix
- Oxford Nanopore
- Panagene
- Primerdesign
- Prominex
- Qiagen (Statdx)
- Quantumdx
- Quidel
- Roche Molecular Diagnostics
- Noticed Diagnostics
- Seegene
- Sensovation
- Siemens Healthineers (Quick Observe Diagnostics)
- SkylineDx
- Sona Nanotech
- T2 Biosystems
- Thermo Fisher
- Veradus Labs
- Veramarx
6. COVID-19 Financial Influence on Gross Home Product
6.1 Financial Influence Overview by Nation
6.2 Tourism International Market by Section-Overview
6.Three Medical International Market by Section and State of affairs-Overview
7. Tourism International Markets-By Section and State of affairs
7.1 Motels
7.2 Floor
7.Three Air Journey
7.Four Cruise Market
7.5 Different Tourism
8. Medical International Markets-By Section and State of affairs
8.1 Therapeutic
8.2 Diagnostics
8.Three PPE
For extra details about this report go to https://www.researchandmarkets.com/r/307pl0
Analysis and Markets additionally provides Custom Research providers offering targeted, complete and tailor-made analysis.
CONTACT: ResearchAndMarkets.com Laura Wooden, Senior Press Supervisor press@researchandmarkets.com For E.S.T Workplace Hours Name 1-917-300-0470 For U.S./CAN Toll Free Name 1-800-526-8630 For GMT Workplace Hours Name +353-1-416-8900
[ad_2]
Source link
